Clinical Trial

Treatment for Methamphetamine-Use Disorder

Study Description

Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]

This study will evaluate the behavioral effects of methamphetamine during maintenance on placebo, duloxetine, methylphenidate and duloxetine combined with methylphenidate using sophisticated human laboratory methods.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Methamphetamine

In each arm, subjects will receive doses of methamphetamine.

Drug - Methylphenidate

In each arm, subjects will receive methylphenidate capsules.

Drug - Placebo oral capsule

In each arm, subjects will receive placebo capsules.

Drug - Duloxetine

Subjects will receive duloxetine capsules in the duloxetine arm.

Additional Information

Official Study Title

A Novel Drug Combination as a Pharmacotherapeutic for Methamphetamine-Use Disorder

Clinical Trial ID

NCT04178993

ParticipAid ID

dNkzLe